Julia Campe
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 23, 2024
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis.
Journal: Oncoimmunology
Published: January 03, 2024
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
Journal: Talanta
Published: July 05, 2023
Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia.
Journal: Leukemia
Published: November 08, 2022
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma.
Journal: Cancer cell
Published: May 19, 2022
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.
Journal: Blood cancer journal
Published: December 14, 2021
T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
Journal: Frontiers in immunology
Published: October 31, 2021
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma.
Journal: Blood
Published: July 23, 2021
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 16, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026